Atlas Trials

A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

Clinical trial NCT05568407 · TERMINATED

Trial details

NCT number
NCT05568407
Sponsor
Pfizer
Status
TERMINATED
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2023-01-18
Primary completion
2023-06-16
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.